Is 4 mg/mL a sensible working concentration for tirzepatide, or should I go lower?

The case in front of me: 4 mg/mL · tirzepatide.

I would like the axes of comparison first and the recommendation second.

I have tried the first option and it works; the question is whether the second is better rather than merely different.

Is there a defensible reason to prefer one, or is this a coin flip?

At 4 mg/mL a 0.25 mg draw is 6.3 units on a U-100 barrel and a 2.4 mg draw is 60. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. Both land on a readable part of a U-100 barrel, which is the entire point of choosing the diluent volume deliberately rather than pouring in a round number. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.

Start from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.

The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.

Reading a lyophilised cake

Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.

Nothing here is medical advice, and research-use material is not approved for human use.

Concentration equals content over volume, and content is not label claim.

Answering this needs the syringe you actually own, because the barrel graduations decide what "readable" means.

Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.

U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.

Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.

Check the vial can physically hold the volume before you draw it up.

This is the one decision in the whole preparation sequence that cannot be revised later, which is why it is worth thirty seconds of arithmetic.

Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.

Specifically, for a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.

Write the concentration on the label at reconstitution, in units per dose.

edited 1 Feb 2026 by j_wierzbicki — expanded the table to cover the lower concentration

The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.

Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.

Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.

Measure a volume you can actually measure. Round numbers, real syringes.

edited 3 Mar 2026 by oona_kekkonen — removed a claim I could not source

Answer first: diluent volume sets concentration and therefore resolution on the syringe barrel, and resolution is free at reconstitution and impossible to recover afterwards.

Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

The general principle here — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science, and it is why licensed presentations contain a surfactant such as polysorbate 20 or 80. A research vial does not, which is precisely why handling matters more, not less.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.